by Jordana Choucair | Mar 14, 2022 | Life Sciences
Pfizer CEO Albert Bourla said on Sunday that a fourth dose of the COVID-19 vaccine will be necessary to continue to help keep hospitalizations manageable and sicknesses milder. He said Pfizer plans to submit data for a fourth COVID-19 dose, and then see what...
by Jordana Choucair | Mar 14, 2022 | Life Sciences
Sanofi SA’s experimental breast cancer treatment failed in a clinical trial, marking a setback for the drugmaker, which had prioritized the medicine and called it “potentially transformative.” In the phase two study, patients with advanced disease...
by Jordana Choucair | Mar 14, 2022 | Opioid/Substance Use Disorders
Black Americans fatally overdosed in 2020 at a higher rate than white Americans for the first time since 1999. The rise of fentanyl, which is more deadly than heroin or prescription opioids, is driving the overdose rate higher and changing its demographics. The...
by Jordana Choucair | Mar 14, 2022 | Providers
The Biden administration is looking to expand a federal COVID-19 data program to track the burden of respiratory and other infectious diseases on hospitals. The current Trump-era system is set to expire with the end of the national emergency, but the Biden...
by Jordana Choucair | Mar 14, 2022 | Providers
Six health systems have formed an alliance aimed at sharing best practices and other data around improving workforce diversity, well-being, and engagement. The “Evolve Health Alliance” is an extension of workforce-focused collaborations struck by the member groups –...
Recent Comments